manufacturing and supply chain management

Coherus Oncology is a commercial-stage company focused on developing and commercializing a diversified portfolio of next-generation immuno-oncology therapies that target the tumor microenvironment and potentially extend patient survival across tumor types. Its FDA-approved therapy LOQTORZI (toripalimab-tpzi) treats recurrent, locally advanced or metastatic nasopharyngeal carcinoma in combination with chemotherapy or as a single agent. The company has multiple clinical-stage immuno-oncology candidates and ongoing clinical trials across cancer indications.

Read more

clinical trialscommercializationimmuno-oncology drug developmentmarketing